Californian “cellular agriculture company” Cellibre has closed a round of funding that will enable it to accelerate the production of pharmaceutical-grade cannabinoids via fermentation
Written by Lorraine Mullaney || 15th December 2020 || News analysis | Companies | Technology and innovation | North America United States